FDA approves first m RNA-based flu vaccine
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
24 sources checked · Left, Center, and Right included · 1h ago
Most headlines factually report the FDA's approval of the first m RNA flu vaccine, with one linking it to the COVID vaccine technology.

MOSTLY SAME
As of August 6, 2026 at 1:56 PM, this is how Optics News reads the wording differences in this story.
24 sources across Left, Center, and Right all describe the same event.
25/99 — small wording differences, not a major framing split.
WHAT EACH SIDE EMPHASIZED
The Guardian US · Center-left · News report
WDSU New Orleans (Hearst) · Center · News report
PJ Media · Right · News report
SEE THE HEADLINES
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The m Flusiva vaccine for older people is first made with m RNA platform key to ending coronavirus pandemic The Food and Drug Administration has approved a new kind of flu vaccine for older...
Takeda's narcolepsy drug approved, the first m RNA flu shot approved, and more biotech updates from The Readout
The shot, made by Moderna, will be available for this year's upcoming flu season.
The U.S. Food and Drug Administration has approved a new m RNA-based seasonal flu vaccine for people 50 and older, Moderna said this week.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
This flu shot, m Flusiva, was shown in a clinical trial to be up to 27 percent more effective than a standard flu jab
The Food and Drug Administration (FDA) late Wednesday approved the nation's first m RNA flu vaccine, manufactured by drugmaker Moderna.
The Food and Drug Administration has approved the first m RNA-based seasonal flu vaccine, which will be available this upcoming flu season.
The Food and Drug Administration (FDA) late Wednesday approved the nation's first m RNA flu vaccine, manufactured by drugmaker Moderna.
SOURCE MAP CHANGES
Aug 6, 12:19 PM: WGN-TV (Nexstar, Chicago) joined the source map.
Aug 6, 12:26 PM: Straight Arrow News joined the source map.
Aug 6, 12:34 PM: KTLA5 (Nexstar, Los Angeles) joined the source map.
Aug 6, 1:00 PM: Scientific American joined the source map.
Now: Wording Gap is 25/99 and story health is stable · 24 sources · all three buckets · comparable news format.